|
J Biol Chem, Vol. 274, Issue 40, 28626-28631, October 1, 1999
Selective Up-regulation of Fatty Acid Uptake by Adipocytes
Characterizes Both Genetic and Diet-induced Obesity in Rodents*
P. D.
Berk §¶,
S.-L.
Zhou ,
C.-L.
Kiang ,
D. D.
Stump ,
X.
Fan , and
M. W.
Bradbury
From the Department of Medicine, Division of Liver
Diseases, and the § Department of Biochemistry, Mount
Sinai School of Medicine, New York, New York 10029
 |
ABSTRACT |
Long chain fatty acid transport is selectively
up-regulated in adipocytes of Zucker fatty rats, diverting fatty acids
from sites of oxidation toward storage in adipose tissue. To determine whether this is a general feature of obesity, we studied
[3H]oleate uptake by adipocytes and hepatocytes
from 1) homozygous male obese (ob), diabetic
(db), fat (fat), and tubby (tub)
mice and from 2) male Harlan Sprague-Dawley rats fed for 7 weeks a diet
containing 55% of calories from fat. Vmax and
Km were compared with controls of the appropriate
background strain (C57BL/6J or C57BLKS) or diet (13% of calories from
fat). Vmax for adipocyte fatty acid uptake was
increased 5-6-fold in ob, db, fat,
and tub mice versus controls
(p < 0.001), whereas no differences were seen in the
corresponding hepatocytes. Similar changes occurred in fat-fed rats. Of
three membrane fatty acid transporters expressed in adipocytes, plasma
membrane fatty acid-binding protein mRNA was increased 9-11-fold
in ob and db, which lack a competent
leptin/leptin receptor system, but was not increased in fat
and tub, i.e. in strains with normal leptin
signaling capability; fatty acid translocase mRNA was increased
2.2-6.5-fold in tub, ob, and fat
adipocytes, but not in db adipocytes; and only marginal changes in fatty acid transport protein 1 mRNA were found in any of
the mutant strains. Adipocyte fatty acid uptake is generally increased
in murine obesity models, but up-regulation of individual transporters
depends on the specific pathophysiology. Leptin may normally
down-regulate expression of plasma membrane fatty acid binding protein.
 |
INTRODUCTION |
In normal man and most mammalian species, body weight is
maintained within narrow limits through regulation of both caloric intake and energy expenditure (1, 2). If caloric intake persistently
exceeds energy expenditure, obesity is an inevitable consequence.
However, there are obvious differences in the tendency to obesity among
individuals with seemingly equivalent caloric intake and similar
degrees of physical activity (3). Likewise, there are differences among
rat strains in the propensity to develop obesity on high fat diets (4).
Finally, a number of single-gene mutations that lead to obesity in mice
and rats have been identified and cloned (5-13), leading in several
instances to elucidation of the mechanisms underlying phenotypic
expression. Studies in these animal models and in obese humans have led
to the concepts of energy efficiency and of nutrient partitioning as
being important physiological mechanisms underlying individual or
strain differences in the propensity to become obese (1, 14, 15).
Individuals with high energy efficiency require fewer calories to meet
basal metabolic needs and accomplish a given level of physical work.
Thus, on a given caloric intake, more calories are, in essence, left
over, and are stored as fat. Individuals with low energy efficiency
utilize more of their caloric intake for basal metabolism and physical
work, leaving fewer calories for storage as fat. The factors
responsible for differences in energy efficiency are incompletely
understood. The concept of nutrient partitioning suggests that the body
may preferentially shunt particular energy substrates either toward
consumption as fuel or into storage as fat. Conceptually, nutrient
partitioning might be one determinant of energy efficiency.
The homozygous obese Zucker fatty rat (fa/fa) is a well
studied animal model in which obesity is a consequence of a mutation in
the leptin receptor (11-13, 16). We have reported that the cellular
uptake of long chain free fatty acids
(LCFFA)1 is selectively
up-regulated in adipocytes of fa/fa animals but is unchanged
in hepatocytes and cardiac myocytes (17). These changes have the effect
of partitioning LCFFA away from tissues in which they would be burned
as fuel into adipocytes, where they are stored as triglyceride.
Adipocyte LCFFA uptake was already up-regulated in 19-21-day
fa/fa weanlings prior to the development of obvious obesity
(17). To determine whether the observed tissue-specific changes in
LCFFA uptake are specific to the Zucker model or are a more general
feature of obesity, studies of LCFFA uptake kinetics were conducted in
homozygous adult male mice of four different strains bearing
obesity-causing mutations and in adult male Harlan Sprague-Dawley rats
fed a high fat diet in which 55% of calories were derived from lard.
Appreciable tissue-specific up-regulation of LCFFA uptake was observed
in adipocytes from all of these animal models of obesity. These results
suggest that, in established obesity resulting from a variety of
different underlying pathogenetic mechanisms, tissue-specific changes
in cellular uptake mechanisms effectively partition LCFFA into storage
within adipocytes, thereby perpetuating the obese phenotype.
 |
EXPERIMENTAL PROCEDURES |
Animals--
Homozygous male obese (ob), diabetic
(db), fat (fat), and tubby (tub) mice
were obtained at 5-10 weeks of age, as available, from The Jackson
Laboratory (Bar Harbor, ME), along with age-matched male C57BL/6J and
C57BLKS control mice. The ob and db mice were overtly overweight on arrival and were studied soon thereafter, at
approximately 9-13 weeks of age. fat and tub
animals were studied at approximately 27-34 weeks of age,
respectively, when they had achieved weights similar to those in the
studied ob and db animals. Normal male Harlan
Sprague-Dawley rats, 8 weeks of age, were obtained from Charles River
Laboratories (Wilmington, MA).
Materials--
9,10-[3H]Oleic acid (2.6 Ci/mmol)
was purchased from NEN Life Science Products, and all routine reagents
were from Sigma. cDNA clones for mAspAT (18), FAT (19), FATP1 (20),
and lipoprotein lipase (LPL) (21) were gifts of Drs. Joseph Mattingly,
Nada Abumrad, Jean Schafer, and Susan Fried, respectively. A rat leptin cDNA was cloned as described previously (22). Appropriate fragments of these cDNAs were labeled by random priming with 32P
(23) for use as probes in Northern hybridization studies. Cell protein
was measured by the bicinchoninic acid assay (BCA* kit, Pierce) and
serum leptin with rat or mouse RIA kits (Linco, St. Charles, MO).
Dietary Studies in Rats--
Twelve 8-10-week-old male Harlan
Sprague-Dawley rats (295 ± 23 g) were randomly assigned to
receive ad libitum either a standard laboratory chow diet
(Ralston-Purina, St. Louis, MO) containing 13% of calories from fat or
a high fat diet containing 35% lard (Bioserve, Frenchtown, NJ), which
provides 55% of calories from fat. Rats were housed in individual
cages with free access to water in a temperature-controlled facility
with a 12-h light/dark cycle. Animals were weighed periodically and
sacrificed after a mean of 50 ± 2 days for tissue harvest and
cellular uptake studies as described below.
Cell Isolation and Characterization--
Suspensions of rat and
mouse hepatocytes (24, 25) and adipocytes (26, 27) were prepared by
collagenase digestion of appropriate tissue samples, as previously
reported. All preparations used in subsequent studies met established
viability criteria (24, 26). In particular, 90% of hepatocytes and
adipocytes excluded trypan blue. To achieve these viability levels in
the fragile adipocytes of obese mouse strains, all mouse adipocytes were suspended in Dulbecco's modified Eagle's medium rather than KRH
(Krebs-Ringer buffer containing 10 mM HEPES, pH 7.4) after isolation and maintained in this medium at room temperature until rewarmed to 37 °C for use. The size distribution of freshly isolated mouse adipocytes was determined by microscopy as described by Di
Girolamo et al. (28).
Cellular Uptake of Oleate--
The initial rate of
[3H]oleate uptake by hepatocytes and by epididymal fat
pad adipocytes was determined by rapid filtration, as described
previously (24, 26, 27, 29). This parameter has been shown principally
to reflect transmembrane transport, relatively independent of
subsequent intracellular binding or metabolism (24, 29). Briefly, cell
preparations with known cell counts were incubated for up to 30 s
at 37 °C in HH (Hanks' buffer containing 10 mM HEPES,
pH 7.4) containing 500 µM BSA and varying
[3H]oleate concentrations and were then filtered and
washed with ice-cold stop solution (24, 26, 29). The filters with the cells were placed in BCS scintillant and counted by liquid
scintillation spectrometry. Oleate uptake by these cell types is linear
within this time period. The slopes of the cumulative uptake
versus time curves, representing initial uptake velocity,
were calculated from this linear portion of the curve by a least mean
squares fit. At the 500 µM BSA concentration employed,
the observed kinetics again reflect membrane transport (30-32),
largely unmodified by such pre-membrane phenomena as rate-limiting
dissociation from albumin and the effects of the pericellular unstirred
water layer on substrate availability at the cell surface (33, 34).
After confirming that observations in epididymal fat pad adipocytes
were reflective of those in intra-abdominal fat pads (17), we
subsequently conducted studies in adipocytes from the former site. This
reduced the numbers of animals necessary for each study. Each oleate
uptake study in hepatocytes and in adipocytes from the ob,
db, fat, and tub mutants was performed
with cells isolated from a single animal. To obtain sufficient cells,
studies in control adipocytes still required pooled cells harvested
from 2-4 mice.
Computations and Data Fitting--
The unbound oleate
concentration (Ou) was calculated from the oleate:BSA molar ratio ( )
(35) using the FFA:BSA binding constants of Spector et al.
(36). Although recent reports (37, 38) suggest that these constants
overestimate Ou, there is no general agreement on alternative values.
Use of the more recent data would modify the computed values of
Km and k but would not change the
conceptual interpretation of these studies. Therefore, we continue to
use the binding constant values of Spector (36), to permit comparison
of these studies with the large body of related earlier work. Based on
prior analyses (39) for each group of animals and cell type studied,
measurements of initial oleate uptake velocity obtained at values of
from 0.1-2.0 were fitted to the sum of a saturable and a
nonsaturable function of the corresponding Ou, using the Simulation,
Analysis and Modeling (SAAM) program of Berman and Weiss (40). SAAM
computes, for each data set, the values of the
Vmax (pmol/s/50,000 cells) and Km (nM) of the saturable uptake function
and the rate constant k (ml/s/50,000 cells) for the
nonsaturable uptake process, as well as their variances and
co-variances. For comparing parameter values obtained for different
experimental groups, the computed statistical parameters are equivalent
to the standard error of the slope of a linear regression (40).
Accordingly, computed values for physiologic variables are also
expressed as mean ± S.E. Differences between groups were
evaluated with two-tailed Student's t tests.
RNA Isolation and Northern Hybridization--
Cellular RNA was
isolated with a guanidinium thiocyanate phenol-chloroform single-step
extraction method (41) using a Stragagene (La Jolla, CA) kit. To
isolate adipocyte RNA, cells were first disrupted and chilled to
4 °C. Aqueous cellular contents were then aspirated with a
micropipette inserted through the layer of congealed lipid that rises
to the top of the tube.2 RNA
extraction then continued as described. RNA samples were separated in
1.2% agarose-formaldehyde gels and transferred to Hybond-N nylon
membranes (Amersham Pharmacia Biotech) in 20× SSC. The membranes were
prehybridized for 3 h and then hybridized overnight to
32P-labeled DNA probes of interest (42). Relative
quantities of message in various samples were determined by
autoradiography. Band intensity was quantitated by scanning
densitometry using a pdi (Huntington Station, NY) Discovery
Scanner, attached to a Sun SPARC work station. Quantity 1 (pdi) software was used to compute the area under the curve
(OD × mm2) for each band of interest. Results were
normalized for lane loading by comparison with the signal intensity
obtained with rodent -actin. The variability of replicate scans of
the same film was less than ±5%. In a series of duplicate studies
with adipocyte RNA samples from paired control mice, the coefficient of
variation for the ratio of bands of interest to actin was ±25%. Accordingly, message levels in mutant mice were considered
significantly increased if densitometric measurements of the
appropriate autoradiographic bands were >1.5-fold those in controls,
after normalization for the corresponding actin signal.
 |
RESULTS |
Studies in Mice
Adipocytes
Animals Studied--
[3H]Oleate uptake by adipocytes
from ob and db animals was studied in mice 12-13
weeks of age, at which time they weighed 2.0 and 1.8 times as much as
their respective age-matched C57BL/6J and C57BLKS controls (Table
I). The tub and fat
animals became obese more slowly, weighing 1.7 and 1.3 times that of
their corresponding control animals when studied at 35 and 27 weeks of
age, respectively. Although adipocyte leptin message levels were
markedly increased in all four mutant strains when compared with their
C57BL/6J and C57BLKS controls (see below), serum leptin levels were
undetectable in the ob animals when assayed with the
antibody supplied by Linco. As reported (43), serum leptin levels were
significantly increased in db, fat, and
tub animals (Table I). Adipocytes isolated from each of the
obese strains were appreciably larger than those of the control animals
(Fig. 1). Calculated cell surface areas
in the mutant strains were 2.9 to 4.2 (mean ± S.E., 3.7 ± 0.4) times those of the controls.
View this table:
[in this window]
[in a new window]
|
Table I
[3H]Oleate uptake studies in adipocytes from mice with
various obesity mutations
Adipocyte sizes are mean values for each strain. All other data are
mean ± S.E.
|
|

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 1.
Size distributions of epididymal fat pad
adipocytes from homozygous male ob and tub mice and C57BK/6J control mice (A) and
homozygous male db and fat mice and
C57BLKS/J controls (B). Surface areas were
computed from the measured diameters on the assumption that isolated
adipocytes are essentially spherical (see Ref. 28).
|
|
Oleate Uptake Kinetics--
Representative LCFFA uptake curves
from each of the mutant strains and from those in corresponding,
age-matched controls are shown in Fig. 2.
Vmax values in all four mutant strains were
significantly increased, ranging from 4.5 to 12.5 times those in the
corresponding controls (Table I). The relative increase in
Vmax averaged 6.8-fold, which is nearly double
the increase in surface area of the corresponding adipocyte
populations. The rate constant for nonsaturable uptake (k)
was also increased by an average of 2.9 ± 0.4-fold in all of the
mutant strains. This increase, which was statistically significant
(p < 0.001) only in the db and
fat animals, was similar to the increase in adipocyte
surface area (p > 0.1), as would be anticipated for a
passive, diffusive process.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 2.
Representative [3H]oleate
uptake curves in isolated adipocytes from homozygous male
ob, db, tub, and
fat mice and the corresponding C57BL/6J and C57BLKS/J
controls. Each curve represents a single study. Data
points depict the mean ± S.D. of triplicate
determinations. Studies in the mutant mice were done on cells from a
single animal. Studies in the control mice were done on cells obtained
from two to four controls.
|
|
Northern Hybridization--
Representative Northern hybridizations
of probes for leptin, FABPpm, FAT, and FATP with adipocyte
RNA from individual mice are illustrated in Fig.
3. The observed ratios of these message levels and that of LPL in mutant animals compared with those in controls are presented in Fig. 4.
Expression of leptin mRNA was consistently up-regulated by a mean
of 7.3-13.7-fold in adipocytes from each of the four mutant strains.
Somewhat smaller and more variable increases (means, 5.1-fold each in
ob, db, and fat and 1.9-fold in
tub) were also observed in lipoprotein lipase message levels. Although the magnitude of the changes showed considerable inter-animal variability (Fig. 4), adipocyte FABPpm
mRNA was increased in all ob (mean, 9-fold) and
db (mean, 11-fold) mice, as it is in the Zucker rat (17).
All of these mutants lack a competent leptin/leptin receptor system. By
contrast, FABPpm mRNA was not increased in any of the
fat or tub animals, i.e. in strains
with normal leptin signaling capability. Adipocyte FAT mRNA was
increased to lesser degrees in fat (mean, 6.5-fold),
ob (mean, 4.2-fold), and tub (mean, 2.2-fold)
mice, but not in db (mean ratio, mutant/control 1.2) mice.
Changes in FATP mRNA levels were marginal in all four mutant
strains.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 3.
Representative Northern blots indicating
mRNA levels in adipocytes from homozygous male ob,
db, tub, and fat mice and the corresponding C57BL/6J and C57BLKS/J controls.
Each band illustrates one of three to seven replicate
analyses of RNA preparations from different animals.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 4.
Results of Northern hybridization analyses of
adipocyte mRNA levels. For each of the indicated messages, the
results are expressed as the ratio of measurements in mutant animals
divided by corresponding measurements in the appropriate control strain
(see text). Each data point represents a single analysis in
one mutant animal. Horizontal bars indicate mean values for
each strain. The shaded band indicates the estimated limits
of variability in normal controls based on measured coefficients of
variation in replicate control studies.
|
|
Hepatocytes
[3H]Oleate uptake in ob and db
mice was studied in hepatocytes harvested from 8-10-week-old animals
that weighed 1.8-2.0 times as much as their respective C57BL/6J and
C57BLKS controls. Hepatocytes from tub and fat
animals were studied at a mean of 31 and 34 weeks of age, when the
animals weighed 2.0 and 1.3 times as much as their corresponding
controls. In hepatocytes, the kinetic parameters in control animals of
each strain were essentially unchanged between the ages of 5 and 34 weeks, and the data were therefore pooled for purposes of comparison
with the mutant animals. As indicated in Table
II, there were no differences between any
of the mutant strains and the appropriate control mice with respect to
any of the kinetic parameters for hepatocyte oleate uptake.
View this table:
[in this window]
[in a new window]
|
Table II
[3H]Oleate uptake studies in hepatocytes from mice with
various obesity mutations
All data are mean ± S.E.
|
|
Rat Studies
Weight Gain
It took approximately 2 weeks for the fat-fed rats to adjust to
the high fat diet, during which their weight gain was slow. However,
they gained weight rapidly thereafter. During the final four weeks of
the study, fat-fed animals gained 139 ± 9 g at an average
rate of 4.8 ± 0.3 g/day, compared with 92 ± 12 g
(p < 0.025) at an average rate of 3.1 ± 0.4 g/day (p < 0.01) for those on the chow diet. In
consequence, despite their slow initial weight gain, fat-fed rats
weighed significantly more than chow-fed animals (533 ± 15 versus 483 ± 15 g, p < 0.05) at
sacrifice. Non-fasting blood glucose levels were normal in both groups
at sacrifice. Plasma FFA concentrations in the fat-fed animals at
sacrifice were 298 ± 93 µM, but in view of the wide
variability, these levels were not significantly increased.
Cellular Fatty Acid Uptake
At sacrifice, the Vmax for adipocyte oleate
uptake was significantly increased in the fat-fed animals compared with
chow-fed controls (4.7 ± 0.6 versus 2.6 ± 0.3 pmol/s/50,000 cells; p < 0.01). By contrast, there
were no significant differences in hepatocyte oleate uptake
Vmax between the fat-fed and chow-fed animals
(0.45 ± 0.13 versus 0.43 ± 0.06 pmol/s/50,000
cells; p > 0.5). There were no appreciable differences
between groups in either adipocyte or hepatocyte Km
or k.
 |
DISCUSSION |
The results presented above indicate that up-regulation of a
saturable process mediating LCFFA uptake occurs selectively in adipocytes from animals with various models of obesity, whereas LCFFA
uptake by hepatocytes is unaltered. These results parallel those
reported earlier in the Zucker fatty (fa/fa) and Zucker diabetic fatty (ZDF) rat (17), in which selective
up-regulation of adipocyte LCFFA uptake was observed with no change in
uptake by either hepatocytes or cardiac myocytes. Although technical difficulties precluded accurate definition of LCFFA uptake by mouse
cardiac myocytes, the implications of the current data are the same as
those in the Zucker animals. Specifically, selective up-regulation of
adipocyte LCFFA uptake is a consistent finding in animals in which
obesity results from a variety of pathogenetic mechanisms. Models
exhibiting this finding include those with defective leptin signaling
caused by mutations in the gene encoding leptin (ob/ob
mouse) or the leptin receptor (db/db mouse, Zucker fa/fa rat), in genetic models in which the mutation does not
involve the leptin system (fat and tub mouse) and
in a widely used "normal" rat strain when fed a high fat diet.
The data suggest that, in each of these models, LCFFA are being
diverted away from tissues such as liver and cardiac muscle, where they
would be burned as fuel or otherwise utilized, and into adipose tissue,
where they are stored as triglyceride. Thus, tissue-specific regulation
of LCFFA uptake represents a form of nutrient partitioning. An
analogous nutrient partitioning mechanism is effected by
tissue-specific regulation of LPL activity. Adipose LPL activity in man
is reportedly increased and that in muscle is decreased by insulin (44,
45), whereas isoproterenol selectively increases LPL activity in muscle
(46). These effects favor either adipose tissue storage or muscle
utilization of LCFFA under different hormonal environments. The
importance for LCFFA disposition of tissue-specific LPL expression has
also been shown in LPL-knockout mice or in transgenic animals
expressing LPL exclusively in muscle (47). Because the enzymatic
activity of LPL generates much of the LCFFA presented to cellular
uptake mechanisms, coordinated expression of LPL and proteins involved
in LCFFA uptake might be anticipated. In the present studies, the
correlation of LPL mRNA levels with those of FABPpm in
the five mice in which both were determined failed to achieve
statistical significance (r = 0.62, p > 0.1), and correlations with FAT (r = 0.42) and FATP1 (r = 0.21) message levels were even weaker.
Nevertheless, this issue merits more detailed attention.
Although this discussion presupposes that cellular uptake of LCFFA
occurs by a facilitated, and therefore regulatable process, the
mechanism(s) by which LCFFA enter cells have, in fact, been controversial. Nevertheless, as recently reviewed in detail (48), the
model most consistent with all currently available data is one in which
LCFFA enter cells by two distinct pathways: a rapid, facilitated
process for the transmembrane movement of fatty acid anions, which
predominates at physiologic concentrations of unbound LCFFA; and a much
slower process reflecting passive flip-flop of the uncharged,
protonated species. In the present study, the proportional increase in
the rate constant for nonsaturable oleate uptake by adipocytes from the
various mouse obesity mutants is quite similar to the increase in
adipocyte surface area, consistent with a passive diffusive process. By
contrast, the increase in Vmax appreciably
exceeds that in surface area, a finding consistent with up-regulation
of a specific transport process. Some researchers still dispute the
existence of facilitated LCFFA uptake mechanisms (49-57). However, a
recent report of a new syndrome in which liver failure in children
results from deficient hepatic uptake of LCFFA clearly indicates the
existence of a membrane transport process that selectively mediates
cellular LCFFA uptake (58).
Even as facilitated LCFFA transport was being disputed, seven plasma
membrane proteins have been proposed as LCFFA transporters. The first
of these described, plasma membrane fatty acid-binding protein
(FABPpm) (59), eventually proved identical to mitochondrial aspartate aminotransferase (60, 61). Despite initial skepticism, substantial evidence establishes that this prototypical mitochondrial enzyme is sorted in regulated fashion to the plasma membrane of selected cell types and functions there to facilitate LCFFA uptake. Fatty acid translocase (FAT) (19) and fatty acid transporting protein
(FATP, now FATP1) (20, 62) were initially reported to be expressed
mainly in adipose tissue and in skeletal and cardiac muscle, but later
studies document appreciable hepatic expression under certain
circumstances (63). Recently, homologues of FATP1, designated
FATP2-FATP5, have been identified and shown to be members of a family
of related transporters, differentially expressed in different tissues
and highly conserved from mycobacteria to man (62). Of these proteins,
FATP5 is expressed exclusively in liver and FATP2 in liver and kidney.
All of these putative FFA transporters increase cellular FFA uptake
following transfection of their cDNAs into non-expressing cell
types. Thus, they all meet the currently accepted criteria for function
as transporters.
In weanling Zucker rats up-regulation of adipocyte LCFFA uptake
precedes overt obesity (17), suggesting that the increase in adipocyte
LCFFA uptake may actually contribute to evolution of the obese
phenotype. Weanling ob, db, fat, and
tub mice were not available for the present studies, so that
changes in LCFFA transport cannot at present be assigned a pathogenetic
role in the corresponding obesity syndromes. What can be inferred is
that the selective up-regulation of adipocyte LCFFA uptake in
established obesity contributes to sustaining the obese phenotype.
Furthermore, the finding that FABPpm is appreciably
up-regulated in obesity models characterized by defective leptin
signaling, but not in those in which the leptin system is normal,
suggests that leptin may normally serve to down-regulate
FABPpm-mediated adipocyte LCFFA uptake. If selective
up-regulation of LCFFA uptake contributes to the pathogenesis and/or
maintenance of the obese phenotype, equally selective, pharmacologic
down-regulation of the same transport process(es) might represent an
important new approach to therapy.
 |
FOOTNOTES |
*
Supported in part by Grants DK-26438 and DK-52401 from the
NIDDK, National Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Div. of Liver
Diseases (Box 1633), Mount Sinai School of Medicine, 1 Gustave L. Levy
Place, New York, NY 10029. Tel.: 212-241-6479; Fax: 212-348-3517; E-mail: paul_berk@smtplink.mssm.edu.
Present address: Institute of Hematology, Beijing Medical
University, 42 Bei-Li-Shi-Lu, Beijing 100044, People's Republic of China.
2
We are indebted to Dr. Susan Fried for
suggesting this procedure.
 |
ABBREVIATIONS |
The abbreviations used are:
LCFFA, long chain
free fatty acids;
LPL, lipoprotein lipase;
BSA, bovine serum albumin;
mAspAT, mitochondrial aspartate aminotransferase;
FABPpm, plasma membrane fatty acid-binding protein;
FAT, fatty acid
translocase;
FATP, fatty acid transporting protein;
Ou, unbound oleate
concentration;
, oleate:BSA molar ratio.
 |
REFERENCES |
| 1.
|
Tataranni, P. A.
(1998)
Diabetes Metab.
24,
108-115[Medline]
[Order article via Infotrieve]
|
| 2.
|
Björntorp, P.
(1998)
in
Handbook of Obesity
(Bray, G. A.
, Bouchard, G.
, and James, W. P. T., eds)
, pp. 573-600, Marcel Dekker, New York
|
| 3.
|
Ravussin, E.,
Lillioja, S.,
Knowler, W. C.,
Christin, L.,
Freymond, D.,
Abbott, W. G.,
Boyce, V.,
Howard, B. V.,
and Bogardus, C.
(1988)
N. Engl. J. Med.
318,
467-472[Abstract]
|
| 4.
|
Schemmel, R.,
Mickelsen, O.,
and Gill, J. L.
(1970)
J. Nutr.
100,
1041-1048
|
| 5.
|
Zhang, Y.,
Proenca, R.,
Maffei, M.,
Barone, M.,
Leopold, L.,
and Friedman, J. M.
(1994)
Nature
372,
425-431[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Chen, H.,
Charlat, O.,
Tartaglia, L. A.,
Woolf, E. A.,
Weng, X.,
Ellis, S. J.,
Lakey, N. D.,
Culpepper, J.,
Moore, K. J.,
Breitbart, R. E.,
Duyk, G. M.,
Tepper, R. I.,
and Morgenstern, J. P.
(1996)
Cell
84,
491-495[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Lee, G.-H.,
Proenca, R.,
Montez, J. M.,
Carroll, K. M.,
Darvishzadeh, J. G.,
Lee, J. I.,
and Friedman, J. M.
(1996)
Nature
379,
632-635[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Noben-Trauth, K.,
Nagert, J. K.,
Noth, M. A.,
and Nishina, P. M.
(1996)
Nature
380,
534-538[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Kleyn, P. W.,
Fan, W.,
Kovats, S. G.,
Lee, J. J.,
Pulido, J. C.,
Wu, Y.,
Berkemeier, L. R.,
Misuni, D. J.,
Holmgren, L.,
Charlat, O.,
Woolf, P. A.,
Tayber, O.,
Brody, T.,
Shu, P.,
Hawkins, F.,
Kennedy, B.,
Baldini, L.,
Ebeling, C.,
Alperin, G. D.,
Deeds, J.,
Lakey, N. D.,
Culpepper, J.,
Chen, H.,
Glucksmann-Kuis, M. A.,
Moore, K. J.,
et al..
(1996)
Cell
85,
281-290[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Miller, M. W.,
Duhl, D. M.,
Vrieling, H.,
Cordes, S. P.,
Ollmann, M. M.,
Winkes, B. M.,
and Barsh, G. S.
(1993)
Genes & Dev.
7,
454-467[Abstract/Free Full Text]
|
| 11.
|
Chua, S. C., Jr,
Chung, W. K.,
Wu-Peng, S.,
Zhang, Y.,
Liu, S.-M.,
Tartaglia, L.,
and Leibel, R. L.
(1996)
Science
271,
994-996[Abstract]
|
| 12.
|
Chua, S. C., Jr.,
White, D. W.,
Sharon Wu-Peng, S.,
Liu, S.-M.,
Okada, N.,
Kershaw, E. E.,
Chung, W. K.,
Power-Kehoe, L.,
CXhua, M.,
Tartaglia, L. A.,
and Leibel, R. L.
(1996)
Diabetes
45,
1141-1143[Abstract]
|
| 13.
|
Phillips, M. S.,
Liu, Q.,
Hammond, H. A.,
Dugan, V.,
Hey, P. J.,
Caskey, C. T.,
and Hess, J. F.
(1996)
Nat. Genet.
13,
18-19[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Astrup, A.,
Raben, A.,
Buemann, B.,
and Toubro, S.
(1997)
Ann. N. Y. Acad. Sci.
827,
417-430[Medline]
[Order article via Infotrieve]
|
| 15.
|
Pagliassotti, M. J.,
Gayles, E. C.,
and Hill, J. O.
(1997)
Ann. N. Y. Acad. Sci.
827,
431-447[Medline]
[Order article via Infotrieve]
|
| 16.
|
Kava, R.,
Greenwood, M. R. C.,
and Johnson, P. R.
(1990)
ILAR News
32,
4-8
|
| 17.
|
Berk, P. D.,
Zhou, S.-L.,
Kiang, C.-L.,
Stump, D.,
Bradbury, M.,
and Isola, L. M.
(1997)
J. Biol. Chem.
272,
8830-8835[Abstract/Free Full Text]
|
| 18.
|
Mattingly, J. R.,
Rodriguez-Berrocal, F. J.,
Gordon, J.,
Iriatre, A.,
and Martinez-Carrion, M.
(1987)
Biochem. Biophys. Res. Commun.
149,
859-865[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Abumrad, N. A.,
Raafat el-Maghrabi, M.,
Amri, E.-Z.,
Lopez, E.,
and Grimaldi, P. A.
(1993)
J. Biol. Chem.
268,
17665-17668[Abstract/Free Full Text]
|
| 20.
|
Schaffer, J. E.,
and Lodish, H. F.
(1994)
Cell
79,
427-436[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Wion, K. L.,
Kirchgessner, T. G.,
Lusis, A. J.,
Schotz, M. C.,
and Laws, R. M.
(1987)
Science
235,
1638-1641[Abstract/Free Full Text]
|
| 22.
|
Murakami, T.,
and Shima, K.
(1995)
Biochem. Biophys. Res. Commun.
209,
944-952[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Feinberg, A. P.,
and Vogelstein, B.
(1983)
Anal. Biochem.
136,
6-13
|
| 24.
|
Stremmel, W.,
and Berk, P. D.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
3086-3090[Abstract/Free Full Text]
|
| 25.
|
Berry, M. N.,
and Friend, D. S.
(1969)
J. Cell Biol.
43,
506-520[Abstract/Free Full Text]
|
| 26.
|
Schwieterman, W.,
Sorrentino, D.,
Potter, B. J.,
Rand, J.,
Kiang, C.-L.,
Stump, D.,
and Berk, P. D.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
359-363[Abstract/Free Full Text]
|
| 27.
|
Whitesell, R. R.,
and Abumrad, N. A.
(1985)
J. Biol. Chem.
260,
2894-2899[Abstract/Free Full Text]
|
| 28.
|
DiGirolamo, M.,
Mendlinger, S.,
and Fertig, J. W.
(1971)
Am. J. Physiol.
221,
850-858[Free Full Text]
|
| 29.
|
Stremmel, W.,
Strohmeyer, G.,
and Berk, P. D.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
3584-3588[Abstract/Free Full Text]
|
| 30.
|
Sorrentino, D.,
Robinson, R. B.,
Kiang, C.-L.,
and Berk, P. D.
(1989)
J. Clin. Invest.
84,
1325-1333
|
| 31.
|
Sorrentino, D.,
Zifroni, A.,
Van Ness, K.,
and Berk, P. D.
(1994)
Am. J. Physiol.
266,
G425-G432[Abstract/Free Full Text]
|
| 32.
|
Sorrentino, D.,
Van Ness, K.,
Stump, D. D.,
and Berk, P. D.
(1994)
J. Hepatol.
21,
551-559[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Sorrentino, D.,
and Berk, P. D.
(1993)
in
Hepatic Transport and Bile Secretion
(Tavoloni, N.
, and Berk, P. D., eds)
, pp. 197-210, Raven Press, New York
|
| 34.
|
Weisiger, R. A.
(1993)
in
Hepatic Transport and Bile Secretion
(Tavoloni, N.
, and Berk, P. D., eds)
, pp. 171-196, Raven Press, New York
|
| 35.
|
Wosilait, W. D.,
and Nagy, P.
(1976)
Comput. Programs Biomed.
6,
142-148[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Spector, A. A.,
Fletcher, J. E.,
and Ashbrook, J. D.
(1971)
Biochemistry
10,
3229-3232[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Richieri, G. V.,
and Kleinfeld, A. M.
(1995)
J. Lipid Res.
36,
229-240[Abstract]
|
| 38.
|
Rose, H.,
Conventz, M.,
Fischer, Y.,
Jüngling, E.,
Hennecke, T.,
and Kammermeier, H.
(1994)
Biochim. Biophys. Acta
1215,
321-326[Medline]
[Order article via Infotrieve]
|
| 39.
|
Stump, D. D.,
Nunes, R. M.,
Sorrentino, D.,
and Berk, P. D.
(1992)
J. Hepatol.
16,
304-315[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Berman, M.,
and Weiss, M. F.
(1967)
Users' Manual for SAAM
, U. S. Public Health Service Publication 1703, Department of Health and Human Services, U. S. Government Printing Office, Washington, D. C.
|
| 41.
|
Chomczynski, P.,
and Sacchi, N.
(1987)
Anal. Biochem.
162,
156-169[Medline]
[Order article via Infotrieve]
|
| 42.
|
Thomas, P. S.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
5201-5205[Abstract/Free Full Text]
|
| 43.
|
Maffei, M.,
Halaas, J.,
Ravussin, E.,
Pratley, R. E.,
Lee, G. H.,
Zhang, Y.,
Fei, H.,
Lallone, R.,
Ranganathan, S.,
Kern, P. M.,
and Friedman, J. A.
(1995)
Nat. Med.
1,
1155-1161[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Farese, R. V., Jr.,
Yost, T. J.,
and Eckel, R. H.
(1991)
Metabolism
40,
214-216[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Kiens, B.,
Lithell, H.,
Mikines, K. J.,
and Richter, E. A.
(1989)
J. Clin. Invest.
84,
1124-1129
|
| 46.
|
Eckel, R. H.,
Jensen, D. N.,
Schlaepper, I. R.,
and Yost, T. J.
(1996)
Am. J. Physiol.
271,
R1280-R1286[Abstract/Free Full Text]
|
| 47.
|
Weinstock, P. H.,
Levak-Frank, S.,
Hudgins, L. C.,
Radner, H.,
Friedman, J. M.,
Zechner, R.,
and Breslow, J. L.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
10261-10266[Abstract/Free Full Text]
|
| 48.
|
Berk, P. D.,
and Stump, D. D.
(1999)
Mol. Cell. Biochem.
192,
17-31[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Noy, N.,
and Zakim, D.
(1993)
in
Hepatic Transport and Bile Secretion
(Tavoloni, N.
, and Berk, P. D., eds)
, pp. 313-335, Raven Press, New York
|
| 50.
|
Zakim, D.
(1996)
Proc. Soc. Exp. Biol. Med.
212,
5-14[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Kamp, F.,
and Hamilton, J. A.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
11367-11370[Abstract/Free Full Text]
|
| 52.
|
Kamp, F.,
and Hamilton, J. A.
(1993)
Biochemistry
32,
11074-11086[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Kamp, F.,
Zakim, D.,
Zhang, F.,
Noy, N.,
and Hamilton, J. A.
(1995)
Biochemistry
34,
11928-11937[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Hamilton, J. A.,
Civelek, V. N.,
Kamp, F.,
Tornheim, K.,
and Corkey, B. A.
(1994)
J. Biol. Chem.
269,
20852-20856[Abstract/Free Full Text]
|
| 55.
|
Civelek, V. N.,
Hamilton, J. A.,
Tornheim, K.,
Kelly, K. L.,
and Corkey, B. A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
10139-10144[Abstract/Free Full Text]
|
| 56.
|
Zakim, D.
(1996)
Proc. Soc. Exp. Biol. Med.
212,
5-14
|
| 57.
|
Hamilton, J. A.
(1998)
J. Lipid Res.
39,
467-481[Abstract/Free Full Text]
|
| 58.
|
Odain, A. A.,
Shneider, B. L.,
Bennett, M. J.,
Pober, B. L.,
Reyes-Mujica, M.,
Friedman, A. L.,
Suchy, F. L.,
and Rinaldo, P.
(1998)
N. Engl. J. Med.
339,
1752-1757[Free Full Text]
|
| 59.
|
Stremmel, W.,
Strohmeyer, G.,
Borchard, F.,
Kochwa, S.,
and Berk, P. D.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
4-8[Abstract/Free Full Text]
|
| 60.
|
Berk, P. D.,
Wada, H.,
Horio, Y.,
Potter, B. J.,
Sorrentino, D.,
Zhou, S.-L.,
Isola, L. M.,
Stump, D.,
Kiang, C.-L.,
and Thung, S.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
3484-3488[Abstract/Free Full Text]
|
| 61.
|
Stump, D. D.,
Zhou, S.-L.,
and Berk, P. D.
(1993)
Am. J. Physiol.
265,
G894-G902[Abstract/Free Full Text]
|
| 62.
|
Hirsch, D.,
Stahl, A.,
and Lodish, H. F.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
8625-8629[Abstract/Free Full Text]
|
| 63.
|
Memon, R. A.,
Feingold, K. R.,
Moser, A. H.,
Fuler, J.,
and Grunfeld, C. A.
(1998)
Am. J. Physiol.
274,
E210-E217[Abstract/Free Full Text]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Bonen, A. Chabowski, J. J. F. P Luiken, and J. F. C. Glatz
Mechanisms and Regulation of Protein-Mediated Cellular Fatty Acid Uptake: Molecular, Biochemical, and Physiological Evidence
Physiology,
February 1, 2007;
22(1):
15 - 28.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. W. Bradbury
Lipid Metabolism and Liver Inflammation. I. Hepatic fatty acid uptake: possible role in steatosis
Am J Physiol Gastrointest Liver Physiol,
February 1, 2006;
290(2):
G194 - G198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Chabowski, S. L. M. Coort, J. Calles-Escandon, N. N. Tandon, J. F. C. Glatz, J. J. F. P. Luiken, and A. Bonen
Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm
Am J Physiol Endocrinol Metab,
October 1, 2004;
287(4):
E781 - E789.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. N. Black and C. C. DiRusso
Transmembrane Movement of Exogenous Long-Chain Fatty Acids: Proteins, Enzymes, and Vectorial Esterification
Microbiol. Mol. Biol. Rev.,
September 1, 2003;
67(3):
454 - 472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Fan, M. W. Bradbury, and P. D. Berk
Leptin and Insulin Modulate Nutrient Partitioning and Weight Loss in ob/ob Mice through Regulation of Long-Chain Fatty Acid Uptake by Adipocytes
J. Nutr.,
September 1, 2003;
133(9):
2707 - 2715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. F. P. Luiken, Y. Arumugam, R. C. Bell, J. Calles-Escandon, N. N. Tandon, J. F. C. Glatz, and A. Bonen
Changes in fatty acid transport and transporters are related to the severity of insulin deficiency
Am J Physiol Endocrinol Metab,
September 1, 2002;
283(3):
E612 - E621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Zou, C. C. DiRusso, V. Ctrnacta, and P. N. Black
Fatty Acid Transport in Saccharomyces cerevisiae. DIRECTED MUTAGENESIS OF FAT1 DISTINGUISHES THE BIOCHEMICAL ACTIVITIES ASSOCIATED WITH Fat1p
J. Biol. Chem.,
August 16, 2002;
277(34):
31062 - 31071.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Endocr. Rev.,
April 1, 2002;
23(2):
201 - 229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. R. Steinberg, D. J. Dyck, J. Calles-Escandon, N. N. Tandon, J. J. F. P. Luiken, J. F. C. Glatz, and A. Bonen
Chronic Leptin Administration Decreases Fatty Acid Uptake and Fatty Acid Transporters in Rat Skeletal Muscle
J. Biol. Chem.,
March 8, 2002;
277(11):
8854 - 8860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Franch, J. Knudsen, B. A. Ellis, P. K. Pedersen, G. J. Cooney, and J. Jensen
Acyl-CoA Binding Protein Expression Is Fiber Type- Specific and Elevated in Muscles From the Obese Insulin-Resistant Zucker Rat
Diabetes,
February 1, 2002;
51(2):
449 - 454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Stump, X. Fan, and P. D. Berk
Oleic acid uptake and binding by rat adipocytes define dual pathways for cellular fatty acid uptake
J. Lipid Res.,
April 1, 2001;
42(4):
509 - 520.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. T. Coburn, F. F. Knapp Jr., M. Febbraio, A. L. Beets, R. L. Silverstein, and N. A. Abumrad
Defective Uptake and Utilization of Long Chain Fatty Acids in Muscle and Adipose Tissues of CD36 Knockout Mice
J. Biol. Chem.,
October 13, 2000;
275(42):
32523 - 32529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. F. P. Luiken, Y. Arumugam, D. J. Dyck, R. C. Bell, M. M. L. Pelsers, L. P. Turcotte, N. N. Tandon, J. F. C. Glatz, and A. Bonen
Increased Rates of Fatty Acid Uptake and Plasmalemmal Fatty Acid Transporters in Obese Zucker Rats
J. Biol. Chem.,
October 26, 2001;
276(44):
40567 - 40573.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|